Spots Global Cancer Trial Database for Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer (BC)
Official Title: Faslodex International Observational Non-Interventional Study in Advanced Breast Cancer
Study ID: NCT00880711
Conditions
Interventions
Study Description
Brief Summary: The purpose is to collect real life data on the use of fulvestrant in normal clinical practice in Austria and document the clinical benefit of fulvestrant treatment.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Research Site, Graz, , Austria
Research Site, Innsbruck, , Austria
Research Site, Klagenfurt, , Austria
Research Site, Leoben, , Austria
Research Site, Linz, , Austria
Research Site, Oberpullendorf, , Austria
Research Site, Rankweil, , Austria
Research Site, Rottenmann, , Austria
Research Site, Salzburg, , Austria
Research Site, St. Veit, , Austria
Research Site, Steyr, , Austria
Research Site, Vienna, , Austria
Research Site, Wr. Neustadt, , Austria
Contact Details
Name: Guenther Steger, Univ Prof. Dr.
Affiliation: Medical University of Vienna
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
